Figure 2.

Disease-free survival according to bcl-2 status in (A) ER-positive and (B) ER-negative pateints. Bcl-2 (+) patients showed better disease-free survival even in those with an ER (+) status, suggesting that bcl-2 has a prognostic role that is independent of ER expression.

Lee et al. BMC Cancer 2007 7:63   doi:10.1186/1471-2407-7-63
Download authors' original image